Reduce patients’ out-of-pocket costs for ARISTADA INITIO™ (aripiprazole lauroxil) and ARISTADA® (aripiprazole lauroxil). Patients with commercial insurance may be eligible to receive assistance to reduce their co-pay to as low as $10 per prescription. Enroll your patients to investigate eligibility.*
*Patients are ineligible for the co-pay program if they are under the age of 18 and/or if they are eligible to purchase their prescription with benefits from Medicare, including Medicare Part D or Medicare Advantage plans; Medicaid, including Medicaid Managed Care or Alternative Benefit Plans (“ABPs”) under the Affordable Care Act; Medigap; Veterans Administration (“VA”); Department of Defense (“DoD”); TriCare®; or any similar state-funded programs such as pharmaceutical assistance programs. Void where prohibited by law, taxed, or restricted. Alkermes, Inc. reserves the right to rescind, revoke, or amend these offers without notice.
The ARISTADA Patient Assistance Program provides uninsured patients who meet program eligibility criteria access to ARISTADA INITIO and ARISTADA treatment at no charge for up to 12 months.†
Definition of uninsured patients
†The ARISTADA Patient Assistance Program does not cover or provide support for supplies, procedures, or any physician-related services associated with ARISTADA therapy.